OURT and GRG isolates have been described previously10 (link), 12 (link). The Vero cell-adapted strain, BA71V40 (link), was used as antigen for the IFA assay. All viruses were generously provided by Dr. Linda Dixon (Pirbright Institute, United Kingdom). All in vitro and in vivo work involving live ASFV was conducted within biosafety level 3 facilities at the AAHL. GRG and OURT were cultured in primary porcine bone marrow (PBM) cells using RPMI media supplemented with glutamine, HEPES, penicillin and streptomycin, Fungizone and 12.5% fetal calf serum (FCS, Serana)41 (link), 42 (link). After 4 days incubation, inoculum was removed, cells were washed, then fixed with cold acetone/methanol for 30 min at room temperature. Cells were washed three times with PBS and incubated for 1 hr at 37 °C with an in-house rabbit anti-ASFV p32 polyclonal antibody diluted in PBS with 1% BSA and 0.005% Evans Blue. Following three washes, Alexa Fluor 488 protein A conjugate (ThermoFisher) was added to each well and incubated for 30 min at 37 °C. Following a final wash step, fluorescence was visualized with an IX71 Olympus inverted fluorescence microscope. TCID50 was calculated according to the method of Reed and Muench43 (link).
Free full text: Click here